Note on laboratory work, October 15, 2026. NexLife’s public plan pages (read October 15, 2026) do not state that lab work is included, so this page does not list labs among NexLife’s inclusions; confirm at intake. NexLife’s plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).
Comparison: Semaglutide vs Tirzepatide
Both items are reviewed at GLP1 One Rx against published clinical evidence.
Key differentiators
- Mechanism: semaglutide is GLP-1-only; tirzepatide is dual GLP-1/GIP.
- Weight loss: tirzepatide produced ~47% greater weight loss than semaglutide 1 mg in SURPASS-2 head-to-head.
- CV outcomes: semaglutide has SELECT (20% MACE reduction); tirzepatide doesn't yet have a published CV outcomes trial.
- Kidney outcomes: semaglutide has FLOW; tirzepatide doesn't.